Skip to main content

Table 2 Logistic regression analysis of the association between RAE1 expression and clinicopathological characteristics in HCC patients

From: RAE1 is a prognostic biomarker and is correlated with clinicopathological characteristics of patients with hepatocellular carcinoma

Characteristics

Total (N)

Odds ratio (OR)

P value

T stage (T2&T3&T4 vs. T1)

371

2.030 (1.345–3.078)

 < 0.001

N stage (N1 vs. N0)

258

2.729 (0.344–55.579)

0.387

M stage (M1 vs. M0)

272

0.971 (0.115–8.185)

0.976

Pathologic stage (Stage III vs. Stage I)

258

2.444 (1.439–4.207)

0.001

Age (> 60 vs. <  = 60)

373

0.928 (0.618–1.394)

0.719

Gender (male vs. female)

374

0.802 (0.519–1.238)

0.320

Tumor status (with tumor vs. Tumor free)

355

1.801 (1.180–2.763)

0.007

Histologic grade (G3 vs. G1)

179

2.543 (1.335–4.929)

0.005

Vascular invasion (Yes vs. No)

318

1.376 (0.866–2.192)

0.177

AFP(ng/ml) (> 400 vs. <  = 400)

280

2.663 (1.504–4.826)

 < 0.001

  1. Black fonts indicate P < 0.05